# The integrative role of melatonin in psychiatric disorders: A systematic review of evidence from circadian biology, lifestyle medicine, and psychoneuroimmunology

**Authors:** Ho Bao Chau Le, Kollawat Somsri, Thansita Bhunyakarnjanarat, Nattiya Hirankarn, Asada Leelahavanichkul

PMC · DOI: 10.37796/2211-8039.1682 · BioMedicine · 2025-12-01

## TL;DR

Melatonin helps regulate sleep and mood, and may be useful in treating psychiatric disorders through its effects on the body's rhythms and immune system.

## Contribution

This paper systematically reviews melatonin's integrative role in psychiatric disorders through circadian biology, lifestyle medicine, and psychoneuroimmunology.

## Key findings

- Melatonin improves sleep quality and restores circadian balance in psychiatric conditions.
- It modulates stress-related neuroimmune pathways and supports neuroplasticity.
- Lifestyle factors enhance melatonin's effects, suggesting a role in multimodal treatment strategies.

## Abstract

Melatonin, a hormone produced by the pineal gland, is known for regulating circadian rhythms and has emerging therapeutic potential in psychiatric disorders. This systematic review examines evidence from clinical and preclinical studies to assess melatonin's efficacy in the following conditions: depression, anxiety, bipolar disorder, and schizophrenia. Beyond its role in circadian regulation, melatonin exhibits antioxidative, anti-inflammatory, and immunomodulatory properties, which intersect with nutrition, lifestyle medicine, and psychoneuroimmunology (PNI).

The review finds that melatonin improves sleep quality, restores circadian balance, and modulates stress-related neuroimmune pathways. It also supports neuroplasticity and reduces oxidative stress, contributing to resilience against psychosocial and environmental stressors. Lifestyle factors, including diet, exercise, and sleep hygiene, enhance melatonin's effects, positioning it as a valuable component of multimodal treatment strategies. Within the PNI framework, melatonin facilitates communication between the nervous and immune systems, offering potential for targeted psychiatric interventions.

This synthesis underscores melatonin's promise as a therapeutic and adjunctive strategy in personalized mental health care. Future research should prioritize rigorous clinical trials, biomarker-driven patient stratification, and integrative approaches combining melatonin with lifestyle interventions and digital health tools to optimize its therapeutic impact.

## Linked entities

- **Chemicals:** melatonin (PubChem CID 896)
- **Diseases:** depression (MONDO:0002050), anxiety (MONDO:0005618), bipolar disorder (MONDO:0004985), schizophrenia (MONDO:0005090)

## Full-text entities

- **Diseases:** psychiatric (MESH:D001523), bipolar disorder (MESH:D001714), depression (MESH:D003866), schizophrenia (MESH:D012559), anxiety (MESH:D001007), inflammatory (MESH:D007249)
- **Chemicals:** Melatonin (MESH:D008550)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12788878/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12788878/full.md

## References

58 references — full list in the complete paper: https://tomesphere.com/paper/PMC12788878/full.md

---
Source: https://tomesphere.com/paper/PMC12788878